Fred Hutch biostatistician Dr. Ruth Etzioni received a seven-year Outstanding Investigator Award (OIA) from the National Cancer Institute to look at multi-cancer early detection tests, commonly referred to as liquid biopsies, and other novel diagnostic technologies..
The 56-gene ctDNA panel is a key component of DefineMBC™, the company’s comprehensive blood biopsy for metastatic breast cancerSAN DIEGO (BUSINESS WIRE) Epic Sciences, Inc. announced today that the company’s 56-gene ctDNA panel for genomic profiling of metastatic breast cancer is covered by the MolDX program (admi.
/PRNewswire/ Epic Sciences, Inc. ("Epic" or "Epic Sciences"), a privately held diagnostics company, has completed a $43 million first close of its Series F.
/PRNewswire/ Epic Sciences, Inc. ("Epic" or "Epic Sciences"), a privately held diagnostics company, has completed a $43 million first close of its Series F.